- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made).
4.—(1) This paragraph defines “net NHS expenditure”, “net NHS wholesale income”, “net purchase amount” and “net sales income” for the purposes of these Regulations.
(2) “Net NHS expenditure” means the total amount paid (in pounds sterling) by a UK producer for UK health service products—
(a)excluding value added taxes, and
(b)after the deduction of—
(i)all discounts and payments, and,
(ii)the value of all payments or benefits in kind,
received in connection with the purchase of those products;
(3) “Net NHS wholesale income” means a UK producer’s total income (in pounds sterling) from the distribution by way of wholesale dealing of UK health service products—
(a)excluding value added taxes, and
(b)after the deduction of—
(i)all discounts and payments, and
(ii)the value of all payments or benefits in kind,
given in connection with the supply of those products.
(4) “Net purchase amount”, in relation to the purchase of a health service product by a UK producer, means the amount paid (in pounds sterling) by the producer for the product—
(a)including any delivery or supply charge (however named) paid in connection with the purchase, but
(b)after the deduction of—
(i)all discounts and payments, and
(ii)the value of all payments or benefits in kind,
received in connection with the purchase.
(5) “Net sales income”, in relation to the supply of a health service product by a UK producer, means the producer’s income (in pounds sterling) from the supply of the product—
(a)including any delivery or supply charge (however named) charged in connection with the supply, but
(b)excluding value added taxes, and
(c)after the deduction of—
(i)all discounts and payments, and
(ii)the value of all payments or benefits in kind,
given in connection with the supply.
(6) For the purposes of sub-paragraphs (2) to (5), it does not matter whether a discount, payment, payment or benefit in kind can be attributed to the supply or, as the case may be, purchase of a particular health service product.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: